<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Kong T</submitter><pubmed_abstract>This study aimed to evaluate the association between the delta neutrophil index (DNI), which reflects immature granulocytes, and the severity of ST-elevation myocardial infarction (STEMI), as well as to determine the significance of the DNI as a prognostic marker for early mortality and other clinical outcomes in patients with STEMI who underwent reperfusion. This retrospective, observational cohort study was conducted using patients prospectively integrated in a critical pathway program for STEMI. We included 842 patients diagnosed with STEMI who underwent primary percutaneous coronary intervention (pPCI). Higher DNI values at time-I (within 2 h of pPCI; hazard ratio [HR], 1.075; 95% confidence interval [CI]: 1.046-1.108; p &lt; 0.001) and time-24 (24 h after admission; HR, 1.066; 95% CI: 1.</pubmed_abstract><journal>Scientific reports</journal><pagination>15718</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5691079</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction.</pubmed_title><pmcid>PMC5691079</pmcid><pubmed_authors>Kim TH</pubmed_authors><pubmed_authors>Park YS</pubmed_authors><pubmed_authors>Lee HS</pubmed_authors><pubmed_authors>Park I</pubmed_authors><pubmed_authors>Hong JH</pubmed_authors><pubmed_authors>Kong T</pubmed_authors><pubmed_authors>You JS</pubmed_authors><pubmed_authors>Chung SP</pubmed_authors><pubmed_authors>Lee JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction.</name><description>This study aimed to evaluate the association between the delta neutrophil index (DNI), which reflects immature granulocytes, and the severity of ST-elevation myocardial infarction (STEMI), as well as to determine the significance of the DNI as a prognostic marker for early mortality and other clinical outcomes in patients with STEMI who underwent reperfusion. This retrospective, observational cohort study was conducted using patients prospectively integrated in a critical pathway program for STEMI. We included 842 patients diagnosed with STEMI who underwent primary percutaneous coronary intervention (pPCI). Higher DNI values at time-I (within 2 h of pPCI; hazard ratio [HR], 1.075; 95% confidence interval [CI]: 1.046-1.108; p &lt; 0.001) and time-24 (24 h after admission; HR, 1.066; 95% CI: 1.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Nov</publication><modification>2025-04-04T14:03:25.554Z</modification><creation>2019-03-27T03:02:15Z</creation></dates><accession>S-EPMC5691079</accession><cross_references><pubmed>29146994</pubmed><doi>10.1038/s41598-017-15878-5</doi></cross_references></HashMap>